Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats
Abstract The unbound concentrations of 14 commercial drugs, including five non‐efflux/uptake transporter substrates—Class I, five efflux transporter substrates—class II and four influx transporter substrates—Class III, were simultaneously measured in rat liver, muscle, and blood via microanalysis. K...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/888cbe7245f6422fa500b10c7fc1165f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:888cbe7245f6422fa500b10c7fc1165f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:888cbe7245f6422fa500b10c7fc1165f2021-11-16T13:45:56ZEffects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats2052-170710.1002/prp2.879https://doaj.org/article/888cbe7245f6422fa500b10c7fc1165f2021-10-01T00:00:00Zhttps://doi.org/10.1002/prp2.879https://doaj.org/toc/2052-1707Abstract The unbound concentrations of 14 commercial drugs, including five non‐efflux/uptake transporter substrates—Class I, five efflux transporter substrates—class II and four influx transporter substrates—Class III, were simultaneously measured in rat liver, muscle, and blood via microanalysis. Kpuu,liver and Kpuu,muscle were calculated to evaluate the membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver. For Class I compounds, represented by antipyrine, unbound concentrations among liver, muscle and blood are symmetrically distributed when compound hepatic clearance is low. And when compound hepatic clearance is high, unbound concentrations among liver, muscle and blood are asymmetrically distributed, such as Propranolol. For Class II and III compounds, overall, the unbound concentrations among liver, muscle, and blood are asymmetrically distributed due to a combination of hepatic metabolism and efflux and/or influx transporter activity.Shuyao WangChun ChenChi GuanLiping QiuLei ZhangShaofeng ZhangHongyu ZhouHongwen DuChen LiYaqiong WuHang ChangTao WangWileyarticleasymmetrically distributedcell metabolismmembrane transportmicroanalysisunbound drug concentrationTherapeutics. PharmacologyRM1-950ENPharmacology Research & Perspectives, Vol 9, Iss 5, Pp n/a-n/a (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
asymmetrically distributed cell metabolism membrane transport microanalysis unbound drug concentration Therapeutics. Pharmacology RM1-950 |
spellingShingle |
asymmetrically distributed cell metabolism membrane transport microanalysis unbound drug concentration Therapeutics. Pharmacology RM1-950 Shuyao Wang Chun Chen Chi Guan Liping Qiu Lei Zhang Shaofeng Zhang Hongyu Zhou Hongwen Du Chen Li Yaqiong Wu Hang Chang Tao Wang Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats |
description |
Abstract The unbound concentrations of 14 commercial drugs, including five non‐efflux/uptake transporter substrates—Class I, five efflux transporter substrates—class II and four influx transporter substrates—Class III, were simultaneously measured in rat liver, muscle, and blood via microanalysis. Kpuu,liver and Kpuu,muscle were calculated to evaluate the membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver. For Class I compounds, represented by antipyrine, unbound concentrations among liver, muscle and blood are symmetrically distributed when compound hepatic clearance is low. And when compound hepatic clearance is high, unbound concentrations among liver, muscle and blood are asymmetrically distributed, such as Propranolol. For Class II and III compounds, overall, the unbound concentrations among liver, muscle, and blood are asymmetrically distributed due to a combination of hepatic metabolism and efflux and/or influx transporter activity. |
format |
article |
author |
Shuyao Wang Chun Chen Chi Guan Liping Qiu Lei Zhang Shaofeng Zhang Hongyu Zhou Hongwen Du Chen Li Yaqiong Wu Hang Chang Tao Wang |
author_facet |
Shuyao Wang Chun Chen Chi Guan Liping Qiu Lei Zhang Shaofeng Zhang Hongyu Zhou Hongwen Du Chen Li Yaqiong Wu Hang Chang Tao Wang |
author_sort |
Shuyao Wang |
title |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats |
title_short |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats |
title_full |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats |
title_fullStr |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats |
title_full_unstemmed |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats |
title_sort |
effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: a microdialysis study in rats |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/888cbe7245f6422fa500b10c7fc1165f |
work_keys_str_mv |
AT shuyaowang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT chunchen effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT chiguan effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT lipingqiu effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT leizhang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT shaofengzhang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT hongyuzhou effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT hongwendu effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT chenli effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT yaqiongwu effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT hangchang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats AT taowang effectsofmembranetransportactivityandcellmetabolismontheunbounddrugconcentrationsintheskeletalmuscleandliverofdrugsamicrodialysisstudyinrats |
_version_ |
1718426490725466112 |